{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:35:43Z","timestamp":1773657343633,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1007\/bf02507103","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T02:57:54Z","timestamp":1160535474000},"page":"358-362","source":"Crossref","is-referenced-by-count":28,"title":["Soluble CD4 and CD8 in serum from patients with localized scleroderma"],"prefix":"10.1007","volume":"288","author":[{"given":"Shinichi","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Ihn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02507103_CR1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.1780260506","volume":"26","author":"K Takehara","year":"1983","unstructured":"Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y (1983) Antinuclear antibodies in localized scleroderma. Arthritis Rheum 26:612\u2013616","journal-title":"Arthritis Rheum"},{"key":"BF02507103_CR2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0190-9622(86)70217-X","volume":"15","author":"A Ruffatti","year":"1986","unstructured":"Ruffatti A, Peserico A, Glorioso S, Fiocco U, Rossi L, Gambari P, Todesco S (1986) Anticentromere antibody in localized scleroderma. J Am Acad Dermatol 15:637\u2013642","journal-title":"J Am Acad Dermatol"},{"key":"BF02507103_CR3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-104-6-849","volume":"104","author":"V Falanga","year":"1986","unstructured":"Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP (1986) Linear scleroderma: clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 104:849\u2013857","journal-title":"Ann Intern Med"},{"key":"BF02507103_CR4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archderm.1987.01660270088021","volume":"123","author":"V Falanga","year":"1987","unstructured":"Falanga V, Medsger TA Jr, Reichlin M (1987) Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 123:350\u2013353","journal-title":"Arch Dermatol"},{"key":"BF02507103_CR5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0190-9622(89)80310-X","volume":"21","author":"K Kikuchi","year":"1989","unstructured":"Kikuchi K, Takehara K, Ishibashi Y (1989) Antinuclear antibodies in localized scleroderma: unique staining in chromosome spreads. J Am Acad Dermatol 21:1301\u20131303","journal-title":"J Am Acad Dermatol"},{"key":"BF02507103_CR6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.1780360815","volume":"36","author":"S Sato","year":"1993","unstructured":"Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, Ishibashi Y, Takehara K (1993) Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36:1137\u20131141","journal-title":"Arthritis Rheum"},{"key":"BF02507103_CR7","first-page":"526","volume":"18","author":"JA Scarola","year":"1975","unstructured":"Scarola JA, Shulman LE (1975) Serologic abnormalities and their significance in localized scleroderma (abstract). Arthritis Rheum 18:526","journal-title":"Arthritis Rheum"},{"key":"BF02507103_CR8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archderm.121.3.345","volume":"121","author":"V Falanga","year":"1985","unstructured":"Falanga V, Medsger TA Jr, Reichlin M (1985) High titers of antibodies to single-stranded DNA in linear scleroderma. Arch Dermatol 121:345\u2013347","journal-title":"Arch Dermatol"},{"key":"BF02507103_CR9","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archderm.1990.01670340120025","volume":"126","author":"K Takehara","year":"1990","unstructured":"Takehara K, Kikuchi K, Soma Y, Igarashi A, Ishibashi Y (1990) Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma. Arch Dermatol 126:1368\u20131369","journal-title":"Arch Dermatol"},{"key":"BF02507103_CR10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archderm.1994.01690100057009","volume":"130","author":"S Sato","year":"1994","unstructured":"Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol 130:1273\u20131277","journal-title":"Arch Dermatol"},{"key":"BF02507103_CR11","doi-asserted-by":"crossref","unstructured":"Sato S, Fujimoto M, Kikuchi K, Ihn H, Takehara K (1996) Elevated soluble CD23 levels in the sera from patients with localized scleroderma. Arch Dermatol Res 288 (in press)","DOI":"10.1007\/BF02505047"},{"key":"BF02507103_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01262331","volume":"287","author":"H Ihn","year":"1995","unstructured":"Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K (1995) Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 287:193\u2013197","journal-title":"Arch Dermatol Res"},{"key":"BF02507103_CR13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/art.1780370618","volume":"37","author":"Y Uziel","year":"1994","unstructured":"Uziel Y, Krafchik BR, Feldman B, Silverman ED, Rubin LA, Laxer RM (1994) Serum levels of soluble interleukin-2 receptor: a marker of disease activity in localized scleroderma. Arthritis Rheum 37:898\u2013901","journal-title":"Arthritis Rheum"},{"key":"BF02507103_CR14","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0190-9622(94)70217-9","volume":"31","author":"S Sato","year":"1994","unstructured":"Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 31:1273\u20131277","journal-title":"J Am Acad Dermatol"},{"key":"BF02507103_CR15","first-page":"612","volume":"26","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1986","unstructured":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1986) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 26:612\u2013616","journal-title":"Arthritis Rheum"},{"key":"BF02507103_CR16","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Krieg T, Black C, Medsger TA Jr, Fleischmajer R, Rowell N, Jablonska, S, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"BF02507103_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.1780370313","volume":"37","author":"S Sato","year":"1994","unstructured":"Sato S, Ihn H, Kikuchi K, Takehara K (1994) Antihistone antibodies in systemic sclerosis: association with pulmonary fibrosis. Arthritis Rheum 37:391\u2013394","journal-title":"Arthritis Rheum"},{"key":"BF02507103_CR18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1084\/jem.158.3.752","volume":"159","author":"J Fujimoto","year":"1983","unstructured":"Fujimoto J, Levy S, Levy R (1983) Spontaneous release of the Leu-2 (T8) molecule from human T cells. J Exp Med 159:752\u2013756","journal-title":"J Exp Med"},{"key":"BF02507103_CR19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1084\/jem.160.1.116","volume":"160","author":"J Fujimoto","year":"1984","unstructured":"Fujimoto J, Stewart S, Levy R (1984) Immunochemical analysis of the released Leu-2 (T8) molecules. J Exp Med 160:116\u2013124","journal-title":"J Exp Med"},{"key":"BF02507103_CR20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1073\/pnas.86.3.998","volume":"86","author":"P Giblin","year":"1989","unstructured":"Giblin P, Ledbetter JA, Kavathas P (1989) A secreted form of the human lymphocyte cell surface molecule CD8 arises from alternative splicing. Proc Natl Acad Sci USA 86:998\u20131002","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02507103_CR21","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.4049\/jimmunol.142.7.2230","volume":"142","author":"BE Tomkinson","year":"1989","unstructured":"Tomkinson BE, Brown MC, Ip SH, Carrabis S, Sullivan JL (1989) Soluble CD8 during T cell activation. J Immunol 142:2230\u20132236","journal-title":"J Immunol"},{"key":"BF02507103_CR22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(92)90103-I","volume":"92","author":"S Sawada","year":"1992","unstructured":"Sawada S, Sugai S, Iijima S, Takei M, Paredes E, Hayama T, Nishinavita S, Hosokawa Y, Horie T, Obara T (1992) Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sj\u00f8gren's syndrome. Am J Med 92:134\u2013140","journal-title":"Am J Med"},{"key":"BF02507103_CR23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2249.1991.tb05785.x","volume":"86","author":"S Furukawa","year":"1991","unstructured":"Furukawa S, Matsubara T, Tsuji K, Motohashi T, Okumura K, Yabata K (1991) Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol 86:134\u2013139","journal-title":"Clin Exp Immunol"},{"key":"BF02507103_CR24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/clin.1993.1096","volume":"68","author":"RN Lipnick","year":"1993","unstructured":"Lipnick RN, Sfikakis PP, Klipple GL, Tsokos GC (1993) Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis. Clin Immunol Immunopathol 68:64\u201367","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02507103_CR25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2249.1990.tb03292.x","volume":"80","author":"JA Symons","year":"1990","unstructured":"Symons JA, Wood NC, Di Giovine FS, Duff GW (1990) Soluble CD8 in patients with rheumatic diseases. Clin Exp Immunol 80:354\u2013359","journal-title":"Clin Exp Immunol"},{"key":"BF02507103_CR26","first-page":"109","volume":"32","author":"G Famularo","year":"1990","unstructured":"Famularo G, Giacomelli R, Sacchetti S, Danese C, Luciani AM, Perego MA, Tonietti G (1990) Soluble CD8 antigen in systemic sclerosis. J Clin Lab Immunol 32:109\u2013112","journal-title":"J Clin Lab Immunol"},{"key":"BF02507103_CR27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/BF02231777","volume":"12","author":"Y Tokano","year":"1993","unstructured":"Tokano Y, Kaneko H, Obara T, Hashimoto H, Okumura K, Hirose S (1993) Soluble CD4 and CD8 molecules in patients with systemic sclerosis. Clin Rheumatol 12:490\u2013493","journal-title":"Clin Rheumatol"},{"key":"BF02507103_CR28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0090-1229(91)90155-4","volume":"58","author":"MB Kahaleh","year":"1991","unstructured":"Kahaleh MB (1991) Soluble immunologic products in scleroderma sera. Clin Immunol Immunopathol 58:139\u2013144","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02507103_CR29","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1073\/pnas.76.8.4061","volume":"76","author":"EL Reinherz","year":"1979","unstructured":"Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1979) Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci USA 76:4061\u20134065","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02507103_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/331082a0","volume":"331","author":"KC Deen","year":"1988","unstructured":"Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, Sweet RW (1988) A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331:82\u201384","journal-title":"Nature"},{"key":"BF02507103_CR31","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI115457","volume":"88","author":"I Kurane","year":"1991","unstructured":"Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janis J, Vergani D (1991) Activation of T lymphocytes in Dengue virus infections. J Clin Invest 88:1473\u20131480","journal-title":"J Clin Invest"},{"key":"BF02507103_CR32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/infdis\/165.5.799","volume":"165","author":"M Peakman","year":"1992","unstructured":"Peakman M, Senaldi G, Foote N, McManus TJ, Vergani D (1992) Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection. J Infect Dis 165:799\u2013804","journal-title":"J Infect Dis"},{"key":"BF02507103_CR33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0090-1229(91)90113-O","volume":"60","author":"JA Symons","year":"1991","unstructured":"Symons JA, McCulloch JF, Wood NC, Duff GW (1991) Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis. Clin Immunol Immunopathol 60:72\u201382","journal-title":"Clin Immunol Immunopathol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02507103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02507103\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02507103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T08:24:40Z","timestamp":1683620680000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02507103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["BF02507103"],"URL":"https:\/\/doi.org\/10.1007\/bf02507103","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}